Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
It's still not clear whether results in secondary care translate to primary care
| The first 150 words of the full text of this article appear below. |
EDITOR
Kalra et al's paper looking at the efficacy of anticoagulation
for stroke prevention in atrial fibrillation1 essentially complements Copland et al's work in showing that an elderly population can be given adequate anticoagulation.2
As Kalra et al performed a cohort study with no control population, the
study does not allow any estimate of the effectiveness of the treatment
as is suggested in the paper. Thus we do not know if there was any
treatment benefit. The cohort obtained similar therapeutic control to
the original trial populations, but this is not a dramatic finding
given that it represents a similar population
that is, patients
selected from medical outpatient clinics. This point seems to have been
lost on Connolly, who in his editorial states, "They screened 2547 patients in general practice clinics."3
As we have consistently argued, the findings of the original
treatment studies and now these newer studies must be